EMBRYONIC DEVELOPMENT & STEM CELL COMPENDIUM
Content
All Cell Therapies > Cell Therapy Card
Sign in for full access

StempeucelICM™, mesenchymal stem cells for ischemic cardiomyopathy

StempeucelICM™ are allogeneic, ex vivo-expanded bone marrow-derived mesenchymal stem cells used to treat ischemic cardiomyopathy.

Phase 1 clinical trial: CTRI/2009/091/000437 Phase 2 clinical trial in Malaysia: SRM/ICM/11-12/002
See additional Cell Therapies for: Heart
StempeucelICM™, mesenchymal stem cells for ischemic cardiomyopathy
Home
Contact Us
About Terms of Use Privacy Policy
Copyright LifeMap Sciences, Inc. - All Rights Reserved (v4.14 Build 1)
This site does not provide medical advice and is for research use only